Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LDX.AU
- Price
- 0.02
- Stock movement up
- +0.00 (4.76%)
- Company name
- Lumos Diagnostics Holdings Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 16.47M
- Ent value
- 29.72M
- Price/Sales
- 1.48
- Price/Book
- 2.32
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -13.54%
- 1 year return
- -59.56%
- 3 year return
- -60.49%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
LDX.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 17.41 |
| Price to FCF | 18.42 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.48 |
| Price to Book | 2.32 |
| EV to Sales | 2.67 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 748.50M |
| EPS (TTM) | -0.02 |
| FCF per share (TTM) | 0.00 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 11.13M |
| Gross profit (TTM) | 6.56M |
| Operating income (TTM) | -5.71M |
| Net income (TTM) | -8.59M |
| EPS (TTM) | -0.02 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 58.96% |
| Operating margin (TTM) | -51.33% |
| Profit margin (TTM) | -77.19% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 6.48M |
| Net receivables | 672.00K |
| Total current assets | 9.56M |
| Goodwill | -6.37M |
| Intangible assets | 3.32M |
| Property, plant and equipment | 10.83M |
| Total assets | 26.84M |
| Accounts payable | 546.00K |
| Short/Current long term debt | 8.06M |
| Total current liabilities | 12.62M |
| Total liabilities | 19.73M |
| Shareholder's equity | 7.11M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 946.00K |
| Capital expenditures (TTM) | 52.00K |
| Free cash flow (TTM) | 894.00K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -120.86% |
| Return on Assets | -32.01% |
| Return on Invested Capital | -106.56% |
| Cash Return on Invested Capital | 11.09% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.02 |
| Daily high | 0.02 |
| Daily low | 0.02 |
| Daily Volume | 237K |
| All-time high | 1.23 |
| 1y analyst estimate | 0.06 |
| Beta | 0.78 |
| EPS (TTM) | -0.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LDX.AU | S&P500 | |
| Current price drop from All-time high | -98.21% | -12.89% |
| Highest price drop | -99.24% | -56.47% |
| Date of highest drop | 29 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -81.89% | -11.07% |
| Avg time to new high | 159 days | 12 days |
| Max time to new high | 918 days | 1805 days |
COMPANY DETAILS
Marketcap
16.47M
Marketcap category
Small-cap
Description
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. Its products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also offers disposable, Lumos Leelu, and hand-held readers. The company was incorporated in 2018 and is based in Carlsbad, California.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found